CELLUM BioMedical

CELLUM BioMedical is a private California-based healthcare company operating a CLIA-certified high-complexity clinical laboratory and positioning itself around regenerative medicine research and translational development. The company became most visible commercially through COVID-19 molecular testing and related specimen collection services, including RT-PCR testing for providers, businesses, and collection sites. Its website also describes broader capabilities in proteins, cell science, and a "bench-to-bedside" model intended to connect laboratory research, clinical testing, and future therapeutics. Publicly available information suggests the business is primarily a diagnostics and laboratory services company rather than a traditional drug-development biotech with a disclosed therapeutic pipeline. Leadership appears closely tied to regenerative medicine and wound-healing interests, including President Richard Chung Jin, who is also associated with BENEV.